Pfizer Announces Late-Stage Trial Success for Multiple Myeloma Therapy Elrexfio

Pfizer has announced a successful outcome in a late-stage clinical trial for its multiple myeloma therapy, Elrexfio. This marks a significant development in the treatment options for the blood cancer.